150 related articles for article (PubMed ID: 25239188)
1. EphB6 promotes anoikis by modulating EphA2 signaling.
Akada M; Harada K; Negishi M; Katoh H
Cell Signal; 2014 Dec; 26(12):2879-84. PubMed ID: 25239188
[TBL] [Abstract][Full Text] [Related]
2. Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase.
Harada K; Hiramoto-Yamaki N; Negishi M; Katoh H
Exp Cell Res; 2011 Jul; 317(12):1701-13. PubMed ID: 21621533
[TBL] [Abstract][Full Text] [Related]
3. Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism.
Hiramoto-Yamaki N; Takeuchi S; Ueda S; Harada K; Fujimoto S; Negishi M; Katoh H
J Cell Biol; 2010 Aug; 190(3):461-77. PubMed ID: 20679435
[TBL] [Abstract][Full Text] [Related]
4. Ephexin4-mediated promotion of cell migration and anoikis resistance is regulated by serine 897 phosphorylation of EphA2.
Kawai H; Kobayashi M; Hiramoto-Yamaki N; Harada K; Negishi M; Katoh H
FEBS Open Bio; 2013; 3():78-82. PubMed ID: 23772378
[TBL] [Abstract][Full Text] [Related]
5. EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity.
Kaibori Y; Saito Y; Nakayama Y
FASEB J; 2019 Apr; 33(4):5334-5349. PubMed ID: 30668924
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.
Fang WB; Ireton RC; Zhuang G; Takahashi T; Reynolds A; Chen J
J Cell Sci; 2008 Feb; 121(Pt 3):358-68. PubMed ID: 18198190
[TBL] [Abstract][Full Text] [Related]
7. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
Fox BP; Kandpal RP
Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
[TBL] [Abstract][Full Text] [Related]
8. RhoG regulates anoikis through a phosphatidylinositol 3-kinase-dependent mechanism.
Yamaki N; Negishi M; Katoh H
Exp Cell Res; 2007 Aug; 313(13):2821-32. PubMed ID: 17570359
[TBL] [Abstract][Full Text] [Related]
9. HGF-induced serine 897 phosphorylation of EphA2 regulates epithelial morphogenesis of MDCK cells in 3D culture.
Harada K; Negishi M; Katoh H
J Cell Sci; 2015 May; 128(10):1912-21. PubMed ID: 25908849
[TBL] [Abstract][Full Text] [Related]
10. Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction.
Allonby O; El Zawily AM; Freywald T; Mousseau DD; Chlan J; Anderson D; Benmerah A; Sidhu V; Babu M; DeCoteau J; Freywald A
Cell Signal; 2014 Dec; 26(12):2645-57. PubMed ID: 25152371
[TBL] [Abstract][Full Text] [Related]
11. Kinase activity-independent role of EphA2 in the regulation of M-phase progression.
Kaibori Y; Katayama K; Tanaka Y; Ikeuchi M; Ogawa M; Ikeda Y; Yuki R; Saito Y; Nakayama Y
Exp Cell Res; 2020 Oct; 395(2):112207. PubMed ID: 32750331
[TBL] [Abstract][Full Text] [Related]
12. EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling.
Singh DR; Ahmed F; King C; Gupta N; Salotto M; Pasquale EB; Hristova K
J Biol Chem; 2015 Nov; 290(45):27271-27279. PubMed ID: 26363067
[TBL] [Abstract][Full Text] [Related]
13. EphA2 induces metastatic growth regulating amoeboid motility and clonogenic potential in prostate carcinoma cells.
Taddei ML; Parri M; Angelucci A; Bianchini F; Marconi C; Giannoni E; Raugei G; Bologna M; Calorini L; Chiarugi P
Mol Cancer Res; 2011 Feb; 9(2):149-60. PubMed ID: 21205836
[TBL] [Abstract][Full Text] [Related]
14. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.
Miao H; Li DQ; Mukherjee A; Guo H; Petty A; Cutter J; Basilion JP; Sedor J; Wu J; Danielpour D; Sloan AE; Cohen ML; Wang B
Cancer Cell; 2009 Jul; 16(1):9-20. PubMed ID: 19573808
[TBL] [Abstract][Full Text] [Related]
15. EphB6 crosslinking results in costimulation of T cells.
Luo H; Yu G; Wu Y; Wu J
J Clin Invest; 2002 Oct; 110(8):1141-50. PubMed ID: 12393850
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation.
Hamaoka Y; Negishi M; Katoh H
Biochem Biophys Res Commun; 2018 May; 499(4):920-926. PubMed ID: 29626472
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
Fang WB; Brantley-Sieders DM; Hwang Y; Ham AJ; Chen J
J Biol Chem; 2008 Jun; 283(23):16017-26. PubMed ID: 18387945
[TBL] [Abstract][Full Text] [Related]
18. Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.
Zhou Y; Yamada N; Tanaka T; Hori T; Yokoyama S; Hayakawa Y; Yano S; Fukuoka J; Koizumi K; Saiki I; Sakurai H
Nat Commun; 2015 Jul; 6():7679. PubMed ID: 26158630
[TBL] [Abstract][Full Text] [Related]
19. Phosphoproteomic profiling of NSCLC cells reveals that ephrin B3 regulates pro-survival signaling through Akt1-mediated phosphorylation of the EphA2 receptor.
Ståhl S; Branca RM; Efazat G; Ruzzene M; Zhivotovsky B; Lewensohn R; Viktorsson K; Lehtiö J
J Proteome Res; 2011 May; 10(5):2566-78. PubMed ID: 21413766
[TBL] [Abstract][Full Text] [Related]
20. Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis.
Cui XD; Lee MJ; Kim JH; Hao PP; Liu L; Yu GR; Kim DG
Hepatology; 2013 Jun; 57(6):2248-60. PubMed ID: 23315987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
